Natco Pharma Ltd News

Midcap Marico, 5 smallcap stocks with 'Double Bottom' pattern on charts

Among smallcaps - Natco Pharma, Neuland Laboratories, Inox India, Welspun Living and GE Shipping shares have witnessed the formation of 'Double Bottom' pattern on the technical charts.

Natco Pharma share price rises 5% on rating update; check key details here

Natco Pharma, in a regulatory filing, has informed the exchanges that the credit rating agency ICRA Limited has reaffirmed and assigned credit ratings for Natco Pharma's various debt instruments.

Natco Pharma shares drop as Chennai plant receives USFDA observations

Natco Pharma shares fell 2 per cent as it received seven observations in the Form-483 from the US Food and Drug Administration

Tejas, Vedant Fashion: Will laggards of Samvat 2081 recover in Samvat 2082?

Among the Nifty 500 constituents, Tejas Networks (down 56 per cent), Praj Industries (down 54 per cent), and Vedant Fashions (down 52 per cent) were among the worst hit

Natco Pharma up 6% as Delhi HC clears SMA drug, rejects Roche appeal

The buying on the counter came after the Delhi High Court dismissed an appeal by F. Hoffmann-La Roche AG, removing the last legal hurdle for Natco Pharma to launch a generic version of Risdiplam

Delhi HC dismisses Roche's plea, allows Natco to sell generic Risdiplam

The court upheld a previous order denying Roche's injunction plea, citing public interest and affordability in treatment for spinal muscular atrophy patients

Natco Pharma surges 5% after USFDA classifies Hyderabad facility as VAI

Natco Pharma stock was trading at ₹884.5, up 3.2 per cent compared to the previous session's close of ₹857.25 on the NSE

Pharma in bitter health: Stocks sink upto 38% in 2025; time to bottom fish?

Among stocks, Natco Pharma plunged 37.85%, Ipca Labs 22.43%, Aurobindo Pharma 17.99%, and Sun Pharma 14.30%. Other laggards include Lupin (13.25%), and Dr Reddy's (5.17%).

Dr Reddy's Labs, Lupin: Nifty Pharma slips 2% amid Trump tariff jitters

Nifty Pharma index declined 1.5 per cent in trade after US President Donald Trump warned to impose a 25 per cent tariff on Indian goods starting August 1

Natco Pharma offers to acquire 35% in Adcock Ingram for ₹2,000 crore

The proposed Rs 2,000 crore deal will give Natco Pharma a strategic foothold in South Africa, with transaction completion expected within four months subject to approvals

Stock calls, July 4: Natco Pharma, Sharda Cropchem among top stocks to buy

Stocks to buy: Analyst pick Sharda Cropchem, Monarch Networth Capital and one more share to buy; Check full details